Quintiles Forms Digital Patient Unit
Research Triangle Park, N.C. -- Quintiles today announced the formation of its new Digital Patient unit, which, for the first time, brings together the company’s online communities and digital expertise to directly engage patients.
The goal of this new organization is to provide patients with information to better manage their personal health and to provide them with opportunities to participate in clinical research, observational studies and programs to better manage their conditions.
“Today, patients are as likely to seek information online about personal health as they are about the weather,” says David Coman, senior vice president at Quintiles and head of its new Digital Patient unit. “By unifying our digital patient resources, we will be better able to deliver proper content to patients while providing our customers with a more efficient channel to find the appropriate people who may be interested in participating in clinical, observational or disease management programs.”
At the core of Quintiles’ new Digital Patient unit is its ability to recruit patients by combing the digital universe for patients seeking information to manage their health, and its two industry-leading patient communities, www.MediGuard.org (2.5 million registered users) and www.ClinicalResearch.com (165 thousand registered users).
MediGuard.org is a free medication monitoring service that provides patients with safety alerts, drug recalls, updates and checks for possible drug interactions. ClinicalResearch.com serves as an information resource with a mission of increasing awareness, understanding and participation in clinical research.
Inquiries on Quintiles’ Digital Patient Unit services should be directed to David Coman via email at firstname.lastname@example.org.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.
Greg Connors, Investor Relations
Office: +1 919 998 2000
Phil Bridges, Media Relations
Office: +1 919 998 1653